Home Healthcare Pharmaceuticals Bioidentical Hormones Market

Bioidentical Hormones Market Size, Share & Trends Analysis Report By Type (Estrogens, Progesterone, Testosterone, Others), By Form (Tablets and capsules, Creams and gels, Injectables, Patches and implants, Others), By Route of Administration (Oral, Parenteral, Topical), By End-use (Hospitals, Gynecology clinics, Research laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Bioidentical Hormones Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Estrogens
    2. Progesterone
    3. Testosterone
    4. Others
  2. Bioidentical Hormones Market, By Form 2022-2034 (USD MILLION/ Units)
    1. Tablets and capsules
    2. Creams and gels
    3. Injectables
    4. Patches and implants
    5. Others
  3. Bioidentical Hormones Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral
    3. Topical
  4. Bioidentical Hormones Market, By End-use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Gynecology clinics
    3. Research laboratories
    4. Others
  5. Regional Bioidentical Hormones Market
    1. North America
      1. North America Bioidentical Hormones Market By Type 2022-2034 (USD MILLION/ Units)
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
      2. North America Bioidentical Hormones Market By Form 2022-2034 (USD MILLION/ Units)
        1. Tablets and capsules
        2. Creams and gels
        3. Injectables
        4. Patches and implants
        5. Others
      3. North America Bioidentical Hormones Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Topical
      4. North America Bioidentical Hormones Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology clinics
        3. Research laboratories
        4. Others
      5. U.S.
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      6. Canada
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
    2. Europe
      1. Europe Bioidentical Hormones Market By Type 2022-2034 (USD MILLION/ Units)
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
      2. Europe Bioidentical Hormones Market By Form 2022-2034 (USD MILLION/ Units)
        1. Tablets and capsules
        2. Creams and gels
        3. Injectables
        4. Patches and implants
        5. Others
      3. Europe Bioidentical Hormones Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Topical
      4. Europe Bioidentical Hormones Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology clinics
        3. Research laboratories
        4. Others
      5. U.K.
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      6. Germany
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      7. France
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      8. Spain
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      9. Italy
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      10. Russia
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      11. Nordic
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      12. Benelux
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      13. Rest of Europe
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
    3. APAC
      1. APAC Bioidentical Hormones Market By Type 2022-2034 (USD MILLION/ Units)
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
      2. APAC Bioidentical Hormones Market By Form 2022-2034 (USD MILLION/ Units)
        1. Tablets and capsules
        2. Creams and gels
        3. Injectables
        4. Patches and implants
        5. Others
      3. APAC Bioidentical Hormones Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Topical
      4. APAC Bioidentical Hormones Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology clinics
        3. Research laboratories
        4. Others
      5. China
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      6. Korea
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      7. Japan
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      8. India
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      9. Australia
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      10. Taiwan
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      11. South East Asia
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      12. Rest of Asia-Pacific
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
    4. Middle East and Africa
      1. Middle East and Africa Bioidentical Hormones Market By Type 2022-2034 (USD MILLION/ Units)
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
      2. Middle East and Africa Bioidentical Hormones Market By Form 2022-2034 (USD MILLION/ Units)
        1. Tablets and capsules
        2. Creams and gels
        3. Injectables
        4. Patches and implants
        5. Others
      3. Middle East and Africa Bioidentical Hormones Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Topical
      4. Middle East and Africa Bioidentical Hormones Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology clinics
        3. Research laboratories
        4. Others
      5. UAE
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      6. Turkey
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      7. Saudi Arabia
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      8. South Africa
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      9. Egypt
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      10. Nigeria
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      11. Rest of MEA
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
    5. LATAM
      1. LATAM Bioidentical Hormones Market By Type 2022-2034 (USD MILLION/ Units)
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
      2. LATAM Bioidentical Hormones Market By Form 2022-2034 (USD MILLION/ Units)
        1. Tablets and capsules
        2. Creams and gels
        3. Injectables
        4. Patches and implants
        5. Others
      3. LATAM Bioidentical Hormones Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Topical
      4. LATAM Bioidentical Hormones Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Gynecology clinics
        3. Research laboratories
        4. Others
      5. Brazil
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      6. Mexico
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      7. Argentina
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      8. Chile
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      9. Colombia
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
      10. Rest of LATAM
        1. Estrogens
        2. Progesterone
        3. Testosterone
        4. Others
        5. Tablets and capsules
        6. Creams and gels
        7. Injectables
        8. Patches and implants
        9. Others
        10. Oral
        11. Parenteral
        12. Topical
        13. Hospitals
        14. Gynecology clinics
        15. Research laboratories
        16. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.